Mandatory notice of trades in IDEX – participation in private placement
IDEX ASA issues this notice on behalf of the primary insiders below. Certain primary insiders acquired shares in IDEX ASA by participating in the private placement of shares on 30 January 2019.
The primary insiders will acquire shares at NOK 4.00 per share, the same price as the other investors participating in the private placement.
Chairman Morten Opstad, through a close associate, will acquire 100,000 shares. After this transaction, Mr. Opstad and close associates will hold 7,298,916 shares in IDEX. Mr. Opstad or his close associates do not hold any other rights to shares in IDEX.
Board member Andy MacLeod will acquire 140,000 shares. After this transaction, Mr. MacLeod will hold 693,475 shares and 500,000 incentive subscription rights in IDEX.
CEO Stan Swearingen will acquire 250,000 shares. After this transaction, Mr. Swearingen will hold 400,000 shares and 6,815,000 incentive subscription rights in IDEX.
CFO Henrik Knudtzon will acquire 100,000 shares. After this transaction, Mr. Knudtzon will hold 150,000 shares and 2,290,000 incentive subscription rights in IDEX.
30 January 2019
For further information contact:
Henrik Knudtzon, CFO
+47 9302 2827
Stuart Hunt, Head of Investor Relations & Communications
+44 1276 534 632
About IDEX Biometrics
IDEX Biometrics, legal name IDEX ASA (OSE: IDEX), is the leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings with the touch of a finger. We invent, engineer and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast-growing multi-billion-unit opportunity.
For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.